9t8a: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal Structure of a de novo CO2 reductase A4== | |||
<StructureSection load='9t8a' size='340' side='right'caption='[[9t8a]], [[Resolution|resolution]] 2.08Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[9t8a]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9T8A OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9T8A FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.08Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PG6:1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE'>PG6</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9t8a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9t8a OCA], [https://pdbe.org/9t8a PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9t8a RCSB], [https://www.ebi.ac.uk/pdbsum/9t8a PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9t8a ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Modern protein design methods based on deep learning allow generation of customized protein scaffolds with diverse geometries and functionalities. Here we capitalize on these recent advances to develop hyper-thermostable de novo CO(2) reductases featuring a cobalt porphyrin IX (CoPPIX) cofactor. CoPPIX-containing enzymes were assembled in vivo through media supplementation with cobalt salts and assessed for photocatalytic CO(2) reductase activity. We identified two cysteine-ligated designs that exhibit high activity (>1000 turnovers at rates of up to 25 min(-1)) while suppressing competing hydrogen evolution pathways. A 2.1 A crystal structure shows close agreement to the design model with the Co-Cys bond programmed as intended. This study showcases the power of computational protein design in developing artificial enzymes to activate challenging molecules such as CO(2). | |||
A De Novo CO(2) Reductase Featuring a Cysteine-Ligated Cobalt Porphyrin Cofactor.,Radley EJ, Andrews AC, Kalvet I, Deng Y, Bell EL, Levy CW, Ortmayer M, Heyes DJ, Megarity CF, Nunez-Franco R, Hutton AE, Lu Y, Baker D, Green AP J Am Chem Soc. 2026 Jul 22;148(28):30194-30201. doi: 10.1021/jacs.6c07615. Epub , 2026 Jul 9. PMID:42425911<ref>PMID:42425911</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: Levy | <div class="pdbe-citations 9t8a" style="background-color:#fffaf0;"></div> | ||
[[Category: Ortmayer | == References == | ||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Synthetic construct]] | |||
[[Category: Levy CW]] | |||
[[Category: Ortmayer M]] | |||